← Portfolio Scout

Portfolio company

Boomerang Medical

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

2 investors

Sectors

Digital Health

About

This company develops bioelectric neuromodulation technology to treat autoimmune diseases, including inflammatory bowel disease, for patients with ulcerative colitis and Crohn's disease.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies